Globus Medical (GMED) Tops Q2 EPS by 2c

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $152.4 million versus the consensus estimate of $151.04 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• John B. Sanfilippo & Son (JBSS) Misses Q4 EPS by 59c
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts